Pharmaceutical

Searchlight licenses Mithra’s menopause drug Donesta for Canadian market

Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees, and milestone-based payments.

Jul 31, 2023 - 20:00
Searchlight licenses Mithra’s menopause drug Donesta for Canadian market
Mithra Pharmaceuticals is in line to receive €17.05m ($18.8m) in licencing fees, and milestone-based payments.
Read the original article

Tags:

Previous Article

Non-profit receives FDA approval to supply cheaper OTC naloxone

Next Article

Santhera fully divests rare eye disease drug Raxone to Chiesi

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

AI drug discovery company Genesis Therapeutics wins $200m in Series B round

AI drug discovery company Genesis Therapeutics wins $20...

Aug 22, 2023

Digital transformation of the supply chain will make data more valuable – are you prepared?

Digital transformation of the supply chain will make da...

Feb 22, 2024

Johnson & Johnson seeks FDA approval for Tremfya for Crohn’s disease

Johnson & Johnson seeks FDA approval for Tremfya for Cr...

Jun 22, 2024